Please be informed project submission for the "Gilead Cell Therapy Grants 2022" is now open!
The Belgian Hematology Society (BHS), with the support of an unrestricted grant from Gilead Sciences and Kite, a Gilead company, has the pleasure to announce two grants to support research in the field of cellular therapies in hematological disease.
Researchers working in hematology are invited to submit their project and apply for the Gilead Cell Therapy Grants. All information on rules and regulations are available on the homepage, as is the application form. The deadline of submission is 1 December 2021, midnight.
The jury will select two winning projects based on their innovative character, which will be awarded with EUR 25.000. The award ceremony will take place at the 37th BHS General Annual Meeting, February 4-5, 2022.
We are looking forward to receiving outstanding projects that can advance the outcomes of hematological diseases through cellular therapies.
Ann Janssens, President of the BHS